Japanese journal of clinical oncologyHumansMaleAgedRetrospective StudiesLung Neoplasms
Prognostic impact of lung metastasis in patients treated with androgen receptor signaling inhibitors for castration-sensitive prostate cancer: data from the ULTRA-Japan Consortium.
Taizo Uchimoto, Kensuke Hirosuna, Heima Niigawa, Sho Kakumae, Hirofumi Morinaka, Wataru Fukuokaya, Atsuhiko Yoshizawa, Masanobu Saruta, Saizo Fujimoto, Tsuyoshi Morita, Yutaka Yamamoto, Moritoshi Sakamoto, Kazuki Nishimura, Ryoichi Maenosono, Takuya Tsujino
Published: 202610.1093/jjco/hyaf161
Abstract
BACKGROUND: Androgen receptor signaling inhibitors (ARSIs) have become the standard treatment for metastatic castration-sensitive prostate cancer (mCSPC). While visceral metastases, including lung metastases (LMs), are considered poor prognostic fact…
Preview only. Read the full abstract at the source